Clinical application of radiofrequency ablation-assisted coaxial trocar biopsies for pulmonary nodules at a high risk of bleeding

The purpose of this study was to assess computed tomography (CT)-guided puncture biopsy of pulmonary nodules at a high risk of bleeding. First, a coaxial trocar technique was used to radiofrequency ablate small blood vessels in the puncture area, followed by a biopsy of the pulmonary nodule. This study aimed to evaluate the effectiveness and safety of this procedure. In this retrospective research, we assessed the relevant data of 45 patients who had undergone needle biopsy of pulmonary nodules at a high risk of bleeding. Twenty-five of these patients had CT-guided coaxial radiofrequency ablation (RFA)-assisted biopsy (group A). The remaining 20 had undergone conventional CT-guided needle biopsy (group B). We equated the technical success rate and the incidence of complications such as bleeding, pneumothorax, and pain in the two groups of needle biopsies. Both groups had a 100% success rate with puncture biopsy. The incidences of pneumothorax in groups A and B were 10% (2/20) and 24% (6/25), respectively; this difference is not significant (P > 0.050). The rates of bleeding in groups A and B were 10% (2/20) and 44% (11/25), respectively, and the rates of pain were 30% (6/20) and 60% (15/25), both of which were statistically significant (P = 0.030; P = 0.045, respectively). CT-guided coaxial trocar technique for RFA-assisted biopsy of pulmonary nodules at a high risk of bleeding is effective and safe and can significantly reduce the risk of biopsy-induced pulmonary hemorrhage.

[1]  Bing Lu,et al.  Hydromorphone vs sufentanil in patient-controlled analgesia for postoperative pain management , 2022, Medicine.

[2]  Zhongmin Wang,et al.  Expert consensus on thermal ablation therapy of pulmonary subsolid nodules (2021 Edition) , 2021, Journal of cancer research and therapeutics.

[3]  G. Lin,et al.  Comparing Patient-Controlled Analgesia Versus Non-PCA Hydromorphone Titration for Severe Cancer Pain: A Randomized Phase III Trial. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[4]  Kaiyi Feng,et al.  Benign pathologies results from lung nodule percutaneous biopsies: How to differentiate true and false benign? , 2021, Journal of cancer research and therapeutics.

[5]  Yunfang Li,et al.  Advances in study of the sequence of lung tumor biopsy and thermal ablation , 2020, Thoracic cancer.

[6]  L. Thabane,et al.  Hydromorphone versus morphine: a historical cohort study to evaluate the quality of postoperative analgesia , 2020, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[7]  A. Ierardi,et al.  RFA of primary and metastatic lung tumors: long-term results , 2020, Medical Oncology.

[8]  B. Li,et al.  Synchronous core-needle biopsy and microwave ablation for highly suspicious malignant pulmonary nodule via a coaxial cannula , 2019, Journal of cancer research and therapeutics.

[9]  M. Bhandari,et al.  Satisfactory analgesia with minimal emesis in day surgeries: a randomised controlled trial of morphine versus hydromorphone. , 2019, British journal of anaesthesia.

[10]  Lujun Shen,et al.  Safety and efficacy of thermal ablation for subpleural lung cancers , 2019, Thoracic cancer.

[11]  Ning Cui,et al.  The value of Cone-Beam CT-guided radiofrequency ablation in the treatment of pulmonary malignancies (≤3 cm) , 2019, Bioscience reports.

[12]  Guangyou Duan,et al.  Effects of patient-controlled analgesia with hydromorphone or sufentanil on postoperative pulmonary complications in patients undergoing thoracic surgery: a quasi-experimental study , 2018, BMC Anesthesiology.

[13]  T. Baère,et al.  Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablation , 2017, European Radiology.

[14]  F. Jacobson,et al.  Frequency and Severity of Pulmonary Hemorrhage in Patients Undergoing Percutaneous CT-guided Transthoracic Lung Biopsy: Single-Institution Experience of 1175 Cases. , 2016, Radiology.

[15]  Y. Yatabe,et al.  Diagnostic Ability of Percutaneous Needle Biopsy Immediately After Radiofrequency Ablation for Malignant Lung Tumors: An Initial Experience , 2016, CardioVascular and Interventional Radiology.

[16]  S. Markowitz,et al.  Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules. , 2007, Chest.

[17]  L. See,et al.  Risk factors for pneumothorax and bleeding after CT-guided percutaneous coaxial cutting needle biopsy of lung lesions. , 2001, Journal of vascular and interventional radiology : JVIR.

[18]  Teus H Kappen,et al.  Postoperative pain assessment based on numeric ratings is not the same for patients and professionals: a cross-sectional study. , 2012, International journal of nursing studies.

[19]  A. Yamamoto,et al.  Frequency and Risk Factors of Various Complications After Computed Tomography–Guided Radiofrequency Ablation of Lung Tumors , 2007, CardioVascular and Interventional Radiology.